Sopharma AD-Sofia (FRA:3JR) Institutional Ownership: 0.31% (As of Sep. 22, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:3JR Sopharma AD-Sofia FRA:3JR
60 GF Score
Price €2.42
GF Value €1.08
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Sopharma AD-Sofia Institutional Ownership?

Sopharma AD-Sofia FRA:3JR +0.41% 60 Institutional Ownership is 0.31% as of Sep. 22, 2026. GuruFocus rates FRA:3JR with a GF Score™ of 60/100 and a GF Value™ of €1.08 (Significantly Overvalued). The stock has 5 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Sopharma AD-Sofia's institutional ownership is 0.31%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Sopharma AD-Sofia's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Sopharma AD-Sofia's Float Percentage Of Total Shares Outstanding is 0.00%.

Sopharma AD-Sofia Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Sopharma AD-Sofia's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sopharma AD-Sofia Institutional Ownership Chart

Sopharma AD-Sofia Historical Data

The historical data trend for Sopharma AD-Sofia can be seen below:

2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30 2026-07-31 2026-08-31
Institutional Ownership 0.32 0.32 0.32 0.32 0.32 0.32 0.32 0.31 0.31 0.31
FRA:3JR
60GF Score
Sopharma AD-Sofia FRA:3JR
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sopharma AD-Sofia Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 0.31% mean?
Sopharma AD-Sofia (FRA:3JR) has a Institutional Ownership of 0.31% as of Sep. 22, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Sopharma AD-Sofia and its competitors.
Is Sopharma AD-Sofia's Institutional Ownership too high?
Sopharma AD-Sofia's current Institutional Ownership is 0.31%. Overall, Sopharma AD-Sofia has a GF Score™ of 60/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Sopharma AD-Sofia's Institutional Ownership compare to MCK and COR?
Sopharma AD-Sofia's Institutional Ownership of 0.31% can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Medical Distribution company?
A good Institutional Ownership depends on the Medical Distribution industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Sopharma AD-Sofia and its competitors. Sopharma AD-Sofia's current Institutional Ownership is 0.31%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sopharma AD-Sofia stock overvalued right now?
Based on GuruFocus' analysis, Sopharma AD-Sofia (FRA:3JR) is currently considered Significantly Overvalued. The stock's GF Value™ is €1.08, compared to a current price of €2.42 — trading 124.1% above its estimated fair value. The current Institutional Ownership is 0.31%. Sopharma AD-Sofia's overall GF Score™ is 60/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Sopharma AD-Sofia (FRA:3JR), the current Institutional Ownership is 0.31% as of Sep. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sopharma AD-Sofia (FRA:3JR) Overvalued in 2026?

Based on GuruFocus' analysis, Sopharma AD-Sofia stock appears to be overvalued. The current stock price of €2.42 is trading 124.1% above its estimated GF Value™ of €1.08. GuruFocus considers Sopharma AD-Sofia to be Significantly Overvalued.

Key valuation signals for FRA:3JR:

  • Institutional Ownership: 0.31%
  • GF Value™: €1.08 vs. price of €2.42 (124.1% above fair value)
  • GF Score™: 60/100 with 5 warning signs

No single metric tells the full story. See the FRA:3JR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sopharma AD-Sofia Business Description

Other Exchanges SPH:PolandSFA:Bulgaria
Address 5 Lachezar Stanchev Street, Sopharma Business Towers, Building A, Floor 12, Sofia, BGR, 1756
Sopharma AD-Sofia is a Bulgarian pharmaceutical company whose principal activities are the production and trade of medicinal substances and finished drug forms, alongside research, development and engineering in the field of medicinal products. It operates through two main segments: the production of pharmaceutical products, including generic medicines, active pharmaceutical ingredients, vitamins and food supplements, and the distribution of pharmaceuticals, medical supplies, sanitary materials and cosmetics. The distribution segment generates the majority of revenue, reflecting Sopharma's extensive wholesale and logistics network serving pharmacies, hospitals and healthcare providers. The company manufactures at facilities in Bulgaria and markets its products both domestically and internationally, exporting to markets across Europe, the CIS and other regions. Sopharma also holds investments in related healthcare and pharmaceutical businesses, and its revenue model combines manufacturing sales of its own branded and generic products with distribution margins from third-party pharmaceutical goods.
60GF Score

Get the complete analysis for FRA:3JR

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.42
Price
€1.08
GF Value